Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation
Clinical trial NCT05576909 · UNKNOWN
Trial details
- NCT number
- NCT05576909
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-30
- Primary completion
- 2024-10-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.